Integra Lifesciences Holdings (IART) Share-based Compensation (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Share-based Compensation of $1.4 million for Q1 2026, down 26.47% on a YoY basis from $1.9 million in Q1 2025, and up 903.65% sequentially from $137000.0 in Q4 2025.
Integra Lifesciences Holdings (IART) Share-based Compensation (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 18 years of Share-based Compensation data on file, last reported at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 26.47% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.2 million (down 2.48% YoY), and the FY2025 full-year result was $2.7 million, down 23.16% from the prior year.
- Share-based Compensation grew to $1.4 million in Q1 2026, from $137000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $11.3 million in Q3 2022 to a low of $81000.0 in Q2 2024.
- A 5-year average of $2.4 million and a median of $491000.0 in 2025 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation tumbled 98.11% in 2023 and soared 506.17% in 2025, its largest moves.
- Tracing IART's Share-based Compensation over 5 years: stood at $3.4 million in 2022, then sank by 90.71% to $314000.0 in 2023, then slumped by 56.69% to $136000.0 in 2024, then advanced by 0.74% to $137000.0 in 2025, then jumped by 903.65% to $1.4 million in 2026.
- Business Quant data shows IART's Share-based Compensation at $1.4 million in Q1 2026, $137000.0 in Q4 2025, and $199000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 137,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 491,000.00 |
| Jun 30, 2025 | 491,000.00 |
| Mar 31, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.87 Mn |
| Dec 31, 2024 | 136,000.00 |
| Dec 31, 2024 | 136,000.00 |
| Sep 30, 2024 | 171,000.00 |
| Sep 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 81,000.00 |
| Jun 30, 2024 | 81,000.00 |
| Mar 31, 2024 | 3.12 Mn |
| Mar 31, 2024 | 3.12 Mn |
| Dec 31, 2023 | 314,000.00 |
| Dec 31, 2023 | 314,000.00 |